BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6348786)

  • 1. Fundamental and clinical studies on intracadaveric organ perfusion with Fluosol-DA.
    Honda K
    Prog Clin Biol Res; 1983; 122():327-30. PubMed ID: 6348786
    [No Abstract]   [Full Text] [Related]  

  • 2. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA.
    Kessler M; Vogel H; Günther H; Harrison DK; Höper J
    Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphology of the pig liver after Fluosol infusion].
    Petutschnigk D; Herrmann M; Hirlinger WK
    Z Mikrosk Anat Forsch; 1980; 94(5):908-12. PubMed ID: 7210801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of fluosol-DA, an artificial blood, on the osmotic fragility of erythrocytes (author's transl)].
    Nogami T; Tsuno K; Yamashiro K; Terasaki H
    Masui; 1980 Nov; 29(12):1495-502. PubMed ID: 7463709
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental normothermic kidney preservation: histological considerations.
    Dunn RN; Merkel FK; Roseman D; Haklin H; English K
    Proc Eur Dial Transplant Assoc; 1981; 18():410-5. PubMed ID: 7036161
    [No Abstract]   [Full Text] [Related]  

  • 7. [Artificial blood. Experimental studies on fluorocarbons as chemical blood substitutes].
    Motta G; Grunert A; Herrmann M; Ratto GB; Spinelli E; Lunghi C; Tomellini M; Bisio E; Hirlinger WK; Mayer M
    Minerva Med; 1983 Jan; 74(1-2):1-18. PubMed ID: 6337348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA.
    Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K
    Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influences of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man].
    Fukushima K; Nakamura M; Hinuma K
    Masui; 1983 Feb; 32(2):192-8. PubMed ID: 6854932
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in cerebral and muscular gas tension during normo-volemic hemodilution with Fluosol-DA in dogs (author's transl)].
    Kosugi I; Kitagaki T; Okada K; Matsushima K
    Kokyu To Junkan; 1980 Apr; 28(4):389-94. PubMed ID: 7403706
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a perfluorochemical emulsion as a blood gas carrier.
    Mitsuno T; Ohyanagi H; Yokoyama K
    Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In mortuo renal perfusion for cadaver kidney preservation.
    Banowsky LH; Sullivan M; Moorehouse J
    Invest Urol; 1971 Nov; 9(3):199-205. PubMed ID: 4944752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood substitutes].
    Tomoda H
    Nihon Rinsho; 1983 Dec; 41(12):2803-9. PubMed ID: 6371303
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of a partial exchange transfusion with Fluosol DA 20% on healthy pigs].
    Hirlinger WK; Grünert A; Herrmann M; Petutschnigk D; Langer K
    Anaesthesist; 1982 Dec; 31(12):660-6. PubMed ID: 7165073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preservation of an isolated kidney in normothermic conditions by perfluorotributylamine emulsion perfusion].
    Kontuganov NN; Shcherbakova NE; Afonin NI; Kirpatovskiĭ VI; Lubiako AA
    Biull Eksp Biol Med; 1983 Mar; 95(3):98-100. PubMed ID: 6830998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
    Shrewsbury RP; White LG
    Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion.
    Ohyanagi H; Nishijima M; Usami M; Nishimatsu S; Matsui E; Saitoh Y
    Prog Clin Biol Res; 1983; 122():315-20. PubMed ID: 6576383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.